Common use of Agency Contacts Clause in Contracts

Agency Contacts. ‌ For questions about program issues contact: Xxxxx X. Xxxx, MPH Division of State Programs Center for Substance Abuse Prevention Substance Abuse and Mental Health Services Administration 0000 Xxxxxxx Xxxx, Xxxx 00X00X Rockville, MD 20857 (000) 000-0000 Phone (000) 000-0000 Fax xxxxx.xxxx@xxxxxx.xxx.xxx Xxxxxxxx Xxxxxxx, MA Division of State Programs Center for Substance Abuse Prevention Substance Abuse and Mental Health Services Administration 0000 Xxxxxxx Xxxx, Xxxx 00X00X Rockville, MD 20857 (000) 000-0000 Phone (000) 000-0000 Fax xxxxxxxx.xxxxxxx@xxxxxx.xxx.xxx For questions on grants management and budget issues contact: Xxxxxx Xxxxxxxx Office of Financial Resources, Division of Grants Management Substance Abuse and Mental Health Services Administration (000) 000-0000 XXXXXXX@xxxxxx.xxx.xxx Appendix A – Confidentiality and SAMHSA Participant Protection/Human Subjects Guidelines‌ Confidentiality and Participant Protection: Because of the confidential nature of the work in which many SAMHSA grantees are involved, it is important to have safeguards protecting individuals from risks associated with their participation in SAMHSA projects. All applicants (including those who plan to obtain IRB approval) must address the seven elements below. If some are not applicable or relevant to the proposed project, simply state that they are not applicable and indicate why. In addition to addressing these seven elements, read the section that follows entitled “Protection of Human Subjects Regulations” to determine if the regulations may apply to your project. If so, you are required to describe the process you will follow for obtaining Institutional Review Board (IRB) approval. While we encourage you to keep your responses brief, there are no page limits for this section and no points will be assigned by the Review Committee. Problems with confidentiality, participant protection, and the protection of human subjects identified during peer review of the application must be resolved prior to funding.

Agency Contacts. ‌ For questions about program issues contact: Xxxxx X. XxxxXxxxxx, MPH LCPC Suicide Prevention Branch, Division of State Prevention, Traumatic Stress and Special Programs Center for Substance Abuse Prevention Mental Health Services Substance Abuse and Mental Health Services Administration 0000 Xxxxxxx 0 Xxxxx Xxxxxx Xxxx, Xxxx 00X00X 0-0000 Rockville, MD 20857 (000) 000-0000 Phone (000) 000-0000 Fax xxxxx.xxxx@xxxxxx.xxx.xxx Xxxxxxxx Xxxxx.xxxxxx@xxxxxx.xxx.xxx Xxxxx X. Xxxxxxx, MA Ph.D. Emergency Mental Health & Traumatic Stress Services Branch, Division of State Prevention, Traumatic Stress and Special Programs Center for Substance Abuse Prevention Mental Health Services Substance Abuse and Mental Health Services Administration 0000 Xxxxxxx 0 Xxxxx Xxxxxx Xxxx, Xxxx 00X00X 0-0000 Rockville, MD 20857 (000) -000-0000 Phone (000) 000-0000 Fax xxxxxxxx.xxxxxxx@xxxxxx.xxx.xxx xxxxx.xxxxxxx@xxxxxx.xxx.xxx For questions on grants management and budget issues contact: Xxxxxx Xxxxxxxx Xxxxxxxxx Xxxxxxx Office of Financial Resources, Division of Grants Management Substance Abuse and Mental Health Services Administration 0 Xxxxx Xxxxxx Xxxx, Xxxx 0-0000 Rockville, Maryland 20857 (000) 000-0000 XXXXXXX@xxxxxx.xxx.xxx xxxxxxxxx.xxxxxxx@xxxxxx.xxx.xxx Appendix A I – Confidentiality and SAMHSA Participant Protection/Human Subjects Guidelines‌ Guidelines Confidentiality and Participant Protection: Because of the confidential nature of the work in which many SAMHSA grantees are involved, it is important to have safeguards protecting individuals from risks associated with their participation in SAMHSA projects. All applicants (including those who plan to obtain IRB approval) must address the seven elements below. If some are not applicable or relevant to the proposed project, simply state that they are not applicable and indicate why. In addition to addressing these seven elements, read the section that follows entitled “Protection of Human Subjects Regulations” to determine if the regulations may apply to your project. If so, you are required to describe the process you will follow for obtaining Institutional Review Board (IRB) approval. While we encourage you to keep your responses brief, there are no page limits for this section and no points will be assigned by the Review Committee. Problems with confidentiality, participant protection, and the protection of human subjects identified during peer review of the application must be resolved prior to funding.

Agency Contacts. ‌ For questions about program issues contact: Xxxxx X. Xxxx, MPH Division of State Programs Center for Substance Abuse Prevention Substance Abuse and Mental Health Services Administration 0000 Xxxxxxx Xxxx, Xxxx 00X00X Rockville, MD 20857 (000) 000-0000 Phone (000) 000-0000 Fax xxxxx.xxxx@xxxxxx.xxx.xxx Xxxxxxxx Xxxxxxx, MA Division of State Programs Center for Substance Abuse Prevention Substance Abuse and Mental Health Services Administration 0000 Xxxxxxx Xxxx, Xxxx 00X00X Rockville, MD 20857 (000) 000-0000 Phone (000) 000-0000 Fax xxxxxxxx.xxxxxxx@xxxxxx.xxx.xxx For questions on grants management and budget issues contact: Xxxxxx Xxxxxxxx Office of Financial Resources, Division of Grants Management Substance Abuse and Mental Health Services Administration (000) 000-0000 XXXXXXX@xxxxxx.xxx.xxx Appendix A – Confidentiality and SAMHSA Participant Protection/Human Subjects Guidelines‌ Guidelines Confidentiality and Participant Protection: Because of the confidential nature of the work in which many SAMHSA grantees are involved, it is important to have safeguards protecting individuals from risks associated with their participation in SAMHSA projects. All applicants (including those who plan to obtain IRB approval) must address the seven elements below. If some are not applicable or relevant to the proposed project, simply state that they are not applicable and indicate why. In addition to addressing these seven elements, read the section that follows entitled “Protection of Human Subjects Regulations” to determine if the regulations may apply to your project. If so, you are required to describe the process you will follow for obtaining Institutional Review Board (IRB) approval. While we encourage you to keep your responses brief, there are no page limits for this section and no points will be assigned by the Review Committee. Problems with confidentiality, participant protection, and the protection of human subjects identified during peer review of the application must be resolved prior to funding.

Agency Contacts. ‌ For questions about program issues contact: Xxxxx X. Xxxx, MPH Xx. Xxxxxxxx Xxxxxx Suicide Prevention Branch Division of State Prevention, Traumatic Stress & Special Programs Center for Substance Abuse Prevention Mental Health Services Substance Abuse and Mental Health Services Administration 0000 Xxxxxxx Xxxx, Xxxx 00X00X Rockville, MD 20857 (000) -000-0000 Phone (000) 000-0000 Fax xxxxx.xxxx@xxxxxx.xxx.xxx Xxxxxxxx Xxxxxxx, MA Division of State Programs Center for Substance Abuse Prevention Substance Abuse and Mental Health Services Administration 0000 Xxxxxxx Xxxx, Xxxx 00X00X Rockville, MD 20857 (000) 000-0000 Phone (000) 000-0000 Fax xxxxxxxx.xxxxxxx@xxxxxx.xxx.xxx xxxxxxxx.xxxxxx@xxxxxx.xxx.xxx For questions on grants management and budget issues contact: Xxxxxx Xxxxxxxx Xxxxxxxxx Xxxxxxx Office of Financial Resources, Division of Grants Management Substance Abuse and Mental Health Services Administration (000) 000-0000 XXXXXXX@xxxxxx.xxx.xxx Appendix A – Confidentiality and SAMHSA Participant Protection/Human Subjects Guidelines‌ Guidelines Confidentiality and Participant Protection: Because of the confidential nature of the work in which many SAMHSA grantees are involved, it is important to have safeguards protecting individuals from risks associated with their participation in SAMHSA projects. All applicants (including those who plan to obtain IRB approval) must address the seven elements below. If some are not applicable or relevant to the proposed project, simply state that they are not applicable and indicate why. In addition to addressing these seven elements, read the section that follows entitled “Protection of Human Subjects Regulations” to determine if the regulations may apply to your project. If so, you are required to describe the process you will follow for obtaining Institutional Review Board (IRB) approval. While we encourage you to keep your responses brief, there are no page limits for this section and no points will be assigned by the Review Committee. Problems with confidentiality, participant protection, and the protection of human subjects identified during peer review of the application must be resolved prior to funding.

Agency Contacts. ‌ For questions about program issues contact: Xxxxx X. XxxxXxxxxxxxxx Deputy Chief Child, MPH Division of State Programs Adolescent and Family Branch Center for Substance Abuse Prevention Mental Health Services Substance Abuse and Mental Health Services Administration 0000 Xxxxxxx Xxxx, Xxxx 00X00X Rockville, MD 20857 (000) 000-0000 Phone (000) 000-0000 Fax xxxxx.xxxx@xxxxxx.xxx.xxx Xxxxxxxx XxxxxxxXxxxx.xxxxxxxxxx@xxxxxx.xxx.xxx Xxxxx Xxxxxx Public Health Advisor/Government Project Officer Child, MA Division of State Programs Adolescent, and Family Branch Center for Substance Abuse Prevention Mental Health Services Substance Abuse and Mental Health Services Administration 0000 Xxxxxxx Xxxxxx Xxxx, Xxxx 00X00X 14N06B Rockville, MD 20857 (000) 000-0000 Phone (000) 000-0000 Fax xxxxxxxx.xxxxxxx@xxxxxx.xxx.xxx xxxxx.xxxxxx@xxxxxx.xxx.xxx For questions on grants management and budget issues contact: Xxxxxx Xxxxxxxx Xxxxxxxxx Xxxxxxx Office of Financial Resources, Division of Grants Management Substance Abuse and Mental Health Services Administration (000) 000-0000 XXXXXXX@xxxxxx.xxx.xxx Appendix A – Confidentiality and SAMHSA Participant Protection/Human Subjects Guidelines‌ Guidelines Confidentiality and Participant Protection: Because of the confidential nature of the work in which many SAMHSA grantees are involved, it is important to have safeguards protecting individuals from risks associated with their participation in SAMHSA projects. All applicants (including those who plan to obtain IRB approval) must address the seven elements below. If some are not applicable or relevant to the proposed project, simply state that they are not applicable and indicate why. In addition to addressing these seven elements, read the section that follows entitled “Protection of Human Subjects Regulations” to determine if the regulations may apply to your project. If so, you are required to describe the process you will follow for obtaining Institutional Review Board (IRB) approval. While we encourage you to keep your responses brief, there are no page limits for this section and no points will be assigned by the Review Committee. Problems with confidentiality, participant protection, and the protection of human subjects identified during peer review of the application must be resolved prior to funding.

Agency Contacts. ‌ For questions about program issues contact: Xxxxx X. Xxxx, MPH Xx. Xxxxxxxx Xxxxxx Suicide Prevention Branch Division of State Prevention, Traumatic Stress & Special Programs Center for Substance Abuse Prevention Mental Health Services Substance Abuse and Mental Health Services Administration 0000 Xxxxxxx Xxxx, Xxxx 00X00X Rockville, MD 20857 (000) -000-0000 Phone (000) 000-0000 Fax xxxxx.xxxx@xxxxxx.xxx.xxx Xxxxxxxx Xxxxxxx, MA Division of State Programs Center for Substance Abuse Prevention Substance Abuse and Mental Health Services Administration 0000 Xxxxxxx Xxxx, Xxxx 00X00X Rockville, MD 20857 (000) 000-0000 Phone (000) 000-0000 Fax xxxxxxxx.xxxxxxx@xxxxxx.xxx.xxx xxxxxxxx.xxxxxx@xxxxxx.xxx.xxx For questions on grants management and budget issues contact: Xxxxxx Xxxxxxxx Xxxxxxxxx Xxxxxxx Office of Financial Resources, Division of Grants Management Substance Abuse and Mental Health Services Administration (000) 000-0000 XXXXXXX@xxxxxx.xxx.xxx Appendix A I – Confidentiality and SAMHSA Participant Protection/Human Subjects Guidelines‌ Guidelines Confidentiality and Participant Protection: Because of the confidential nature of the work in which many SAMHSA grantees are involved, it is important to have safeguards protecting individuals from risks associated with their participation in SAMHSA projects. All applicants (including those who plan to obtain IRB approval) must address the seven elements below. If some are not applicable or relevant to the proposed project, simply state that they are not applicable and indicate why. In addition to addressing these seven elements, read the section that follows entitled “Protection of Human Subjects Regulations” to determine if the regulations may apply to your project. If so, you are required to describe the process you will follow for obtaining Institutional Review Board (IRB) approval. While we encourage you to keep your responses brief, there are no page limits for this section and no points will be assigned by the Review Committee. Problems with confidentiality, participant protection, and the protection of human subjects identified during peer review of the application must be resolved prior to funding.

Agency Contacts. ‌ For questions about program issues contact: Xxxxx X. Xxxx, MPH Xx. Xxxxxxxx Xxxxxx Suicide Prevention Branch Division of State Prevention, Traumatic Stress & Special Programs Center for Substance Abuse Prevention Mental Health Services Substance Abuse and Mental Health Services Administration 0000 Xxxxxxx Xxxx, Xxxx 00X00X Rockville, MD 20857 (000) -000-0000 Phone (000) 000-0000 Fax xxxxx.xxxx@xxxxxx.xxx.xxx Xxxxxxxx Xxxxxxx, MA Division of State Programs Center for Substance Abuse Prevention Substance Abuse and Mental Health Services Administration 0000 Xxxxxxx Xxxx, Xxxx 00X00X Rockville, MD 20857 (000) 000-0000 Phone (000) 000-0000 Fax xxxxxxxx.xxxxxxx@xxxxxx.xxx.xxx xxxxxxxx.xxxxxx@xxxxxx.xxx.xxx For questions on grants management and budget issues contact: Xxxxxx Xxxxxxxx Xxxxxxxxx Xxxxxxx Office of Financial Resources, Division of Grants Management Substance Abuse and Mental Health Services Administration (000) 000-0000 XXXXXXX@xxxxxx.xxx.xxx Appendix A – Confidentiality and SAMHSA Participant Protection/Human Subjects Guidelines‌ Confidentiality and Participant Protection: Because of the confidential nature of the work in which many SAMHSA grantees are involved, it is important to have safeguards protecting individuals from risks associated with their participation in SAMHSA projects. All applicants (including those who plan to obtain IRB approval) must address the seven elements below. If some are not applicable or relevant to the proposed project, simply state that they are not applicable and indicate why. In addition to addressing these seven elements, read the section that follows entitled “Protection of Human Subjects Regulations” to determine if the regulations may apply to your project. If so, you are required to describe the process you will follow for obtaining Institutional Review Board (IRB) approval. While we encourage you to keep your responses brief, there are no page limits for this section and no points will be assigned by the Review Committee. Problems with confidentiality, participant protection, and the protection of human subjects identified during peer review of the application must be resolved prior to funding.

Agency Contacts. ‌ For questions about program issues contact: Xxxxx X. XxxxXxxx Public Health Advisor/Government Project Officer Child, MPH Division of State Programs Adolescent and Family Branch Center for Substance Abuse Prevention Mental Health Services Substance Abuse and Mental Health Services Administration 0000 Xxxxxxx 0 Xxxxx Xxxxxx Xxxx, Xxxx 00X00X 0-0000 Rockville, MD 20857 (000) 000-0000 Phone (000) 000-0000 Fax xxxxx.xxxx@xxxxxx.xxx.xxx Xxxxxxxx XxxxxxxXxxxx Xxxxxxxxxx Deputy Chief Child, MA Division of State Programs Adolescent, and Family Branch Federal Center for Substance Abuse Prevention Substance Abuse and Mental Health Services Administration 0000 Xxxxxxx 0 Xxxxx Xxxxxx Xxxx, Xxxx 00X00X 0-0000 Rockville, MD Maryland 20857 (000) 000-0000 Phone (000) 000-0000 Fax xxxxxxxx.xxxxxxx@xxxxxx.xxx.xxx xxxxx.xxxxxxxxxx@xxxxxx.xxx.xxx For questions on grants management and budget issues contact: Xxxxxx Xxxxxxxx Xxxxxxxxx Xxxxxxx Office of Financial Resources, Division of Grants Management Substance Abuse and Mental Health Services Administration 0 Xxxxx Xxxxxx Xxxx, Xxxx 0-0000 Rockville, Maryland 20857 (000) 000-0000 XXXXXXX@xxxxxx.xxx.xxx xxxxxxxxx.xxxxxxx@xxxxxx.xxx.xxx Appendix A I – Confidentiality and SAMHSA Participant Protection/Human Subjects Guidelines‌ Guidelines Confidentiality and Participant Protection: Because of the confidential nature of the work in which many SAMHSA grantees are involved, it is important to have safeguards protecting individuals from risks associated with their participation in SAMHSA projects. All applicants (including those who plan to obtain IRB approval) must address the seven elements below. If some are not applicable or relevant to the proposed project, simply state that they are not applicable and indicate why. In addition to addressing these seven elements, read the section that follows entitled “Protection of Human Subjects Regulations” to determine if the regulations may apply to your project. If so, you are required to describe the process you will follow for obtaining Institutional Review Board (IRB) approval. While we encourage you to keep your responses brief, there are no page limits for this section and no points will be assigned by the Review Committee. Problems with confidentiality, participant protection, and the protection of human subjects identified during peer review of the application must be resolved prior to funding.

Agency Contacts. ‌ For questions about program issues contact: Xxxxx X. XxxxXxxxxxxxxx Deputy Chief Child, MPH Division of State Programs Adolescent, and Family Branch Center for Substance Abuse Prevention Mental Health Services Substance Abuse and Mental Health Services Administration 0000 Xxxxxxx Xxxx, Xxxx 00X00X Rockville, MD 20857 (000) 000-0000 Phone (000) 000-0000 Fax xxxxx.xxxx@xxxxxx.xxx.xxx Xxxxxxxx Xxxxxxxxxxxx.xxxxxxxxxx@xxxxxx.xxx.xxx OR Xxxxx Xxxxxx Public Health Advisor/Government Project Officer Child, MA Division of State Programs Adolescent, and Family Branch Center for Substance Abuse Prevention Mental Health Services Substance Abuse and Mental Health Services Administration 0000 Xxxxxxx Xxxxxx Xxxx, Xxxx 00X00X 14N06B Rockville, MD 20857 (000240) 000-0000 Phone (000) 000-0000 Fax xxxxxxxx.xxxxxxx@xxxxxx.xxx.xxx 276- 0307 xxxxx.xxxxxx@xxxxxx.xxx.xxx For questions on grants management and budget issues contact: Xxxxxx Xxxxxxxx Xxxxxxxxx Xxxxxxx Office of Financial Resources, Division of Grants Management Substance Abuse and Mental Health Services Administration 0000 Xxxxxxx Xxxx, 00X00X Rockville, MD 20857 (000) 000-0000 XXXXXXX@xxxxxx.xxx.xxx xxxxxxxxx.xxxxxxx@xxxxxx.xxx.xxx Appendix A I – Confidentiality and SAMHSA Participant Protection/Human Subjects Guidelines‌ Guidelines Confidentiality and Participant Protection: Because of the confidential nature of the work in which many SAMHSA grantees are involved, it is important to have safeguards protecting individuals from risks associated with their participation in SAMHSA projects. All applicants (including those who plan to obtain IRB approval) must address the seven elements below. If some are not applicable or relevant to the proposed project, simply state that they are not applicable and indicate why. In addition to addressing these seven elements, read the section that follows entitled “Protection of Human Subjects Regulations” to determine if the regulations may apply to your project. If so, you are required to describe the process you will follow for obtaining Institutional Review Board (IRB) approval. While we encourage you to keep your responses brief, there are no page limits for this section and no points will be assigned by the Review Committee. Problems with confidentiality, participant protection, and the protection of human subjects identified during peer review of the application must be resolved prior to funding.

Agency Contacts. ‌ For questions about program issues contact: Xxxxx Xxxxxxxx X. XxxxXxxxxxxxx, MPH Division of State Programs Center for Substance Abuse Prevention PsyD Public Health Advisor Substance Abuse and Mental Health Services Administration 0000 Xxxxxxx Xxxx, 0 Xxxxx Xxxxxx Xxxx 00X00X Room 6-1132 Rockville, MD 20857 (000) 000-0000 Phone (000) 000-0000 Fax xxxxx.xxxx@xxxxxx.xxx.xxx Xxxxxxxx Xxxxxxx, MA Division of State Programs Center for Substance Abuse Prevention Substance Abuse and Mental Health Services Administration 0000 Xxxxxxx Xxxx, Xxxx 00X00X Rockville, MD 20857 (000) 000-0000 Phone (000) 000-0000 Fax xxxxxxxx.xxxxxxx@xxxxxx.xxx.xxx XXXXXX.xxx@XXXXXX.xxx.xxx For questions on grants management and budget issues contact: Xxxxxx Xxxxxxxx Xxxxxxxxx Xxxxxxx Office of Financial Resources, Division of Grants Management Substance Abuse and Mental Health Services Administration 0 Xxxxx Xxxxxx Xxxx Room 7-1091 Rockville, Maryland 20857 (000) 000-0000 XXXXXXX@xxxxxx.xxx.xxx xxxxxxxxx.xxxxxxx@xxxxxx.xxx.xxx Appendix A I – Confidentiality and SAMHSA Participant Protection/Human Subjects Guidelines‌ Guidelines Confidentiality and Participant Protection: Because of the confidential nature of the work in which many SAMHSA grantees are involved, it is important to have safeguards protecting individuals from risks associated with their participation in SAMHSA projects. All applicants (including those who plan to obtain IRB approval) must address the seven elements below. If some are not applicable or relevant to the proposed project, simply state that they are not applicable and indicate why. In addition to addressing these seven elements, read the section that follows entitled “Protection of Human Subjects Regulations” to determine if the regulations may apply to your project. If so, you are required to describe the process you will follow for obtaining Institutional Review Board (IRB) approval. While we encourage you to keep your responses brief, there are no page limits for this section and no points will be assigned by the Review Committee. Problems with confidentiality, participant protection, and the protection of human subjects identified during peer review of the application must be resolved prior to funding.